ProSciento for Clinical Research, Inc. Appoints Dr. Christian Weyer As President And Chief Development Officer

ProSciento for Clinical Research, Inc. Appoints Dr. Christian Weyer As President And Chief Development Officer

December 1, 2015 — ProSciento Inc., a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today the addition of Christian Weyer, M.D., M.A.S. to its executive management team as President and Chief Development Officer. “Building upon its long-standing scientific reputation, therapeutic focus, track record of clinical trial execution, and growing network of metabolic research partners, ProSciento is uniquely positioned to further expand its global leadership as the partner of choice for metabolic R&D,” said Dr. Weyer.

 Read the full article at FierceBiotech »